SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950133-02-002461
Filing Date
2002-07-02
Accepted
2002-07-02 17:00:19
Documents
6
Period of Report
2002-06-26
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K w61907e8vk.htm 8-K 9060
3 PRESS RELEASE w61907exv99w1.htm EX-99.1 8851
4 JUNE 2002 NOTE PURCHASE AGREEMENT w61907exv99w2.htm EX-99.2 100566
5 CONVERTIBLE NOTE w61907exv99w3.htm EX-99.3 43242
6 AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT w61907exv99w4.htm EX-99.4 126393
7 THIRD AMENDMENT TO THE CO-PROMOTION AGREEMENT w61907exv99w5.htm EX-99.5 12660
  Complete submission text file 0000950133-02-002461.txt   303059
Mailing Address 8320 GUILFORD ROAD SUITE C 12111 PARKLAWN DR COLUMBIA MD 21046
Business Address 8320 GUILFORD RD STE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 02695282
SIC: 2836 Biological Products, (No Diagnostic Substances)